Innovative drug approvals up sharply in 2011, gov’t increasingly funds infectious disease R&D
January 25, 2012
The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases long-ignored by drug companies. (Washington Post)
